Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

96 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Population Pharmacokinetic Analysis and Dosing Optimization Based on Unbound Daptomycin Concentration and Cystatin C in Nonobese Elderly Patients with Hypoalbuminemia and Chronic Kidney Disease.
Samura M, Takada K, Yamamoto R, Ito H, Nagumo F, Uchida M, Kurata T, Koshioka S, Enoki Y, Taguchi K, Higashita R, Kunika N, Tanikawa K, Matsumoto K. Samura M, et al. Pharm Res. 2021 Jun;38(6):1041-1055. doi: 10.1007/s11095-021-03058-0. Epub 2021 May 19. Pharm Res. 2021. PMID: 34013390
Identification of Risk Factors for Daptomycin-Associated Creatine Phosphokinase Elevation and Development of a Risk Prediction Model for Incidence Probability.
Samura M, Hirose N, Kurata T, Takada K, Nagumo F, Koshioka S, Ishii J, Uchida M, Inoue J, Enoki Y, Taguchi K, Higashita R, Kunika N, Tanikawa K, Matsumoto K. Samura M, et al. Open Forum Infect Dis. 2021 Nov 10;8(12):ofab568. doi: 10.1093/ofid/ofab568. eCollection 2021 Dec. Open Forum Infect Dis. 2021. PMID: 34888403 Free PMC article.
Efficacy and Safety of Daptomycin versus Vancomycin for Bacteremia Caused by Methicillin-Resistant Staphylococcus aureus with Vancomycin Minimum Inhibitory Concentration > 1 µg/mL: A Systematic Review and Meta-Analysis.
Samura M, Kitahiro Y, Tashiro S, Moriyama H, Hamamura Y, Takahata I, Kawabe R, Enoki Y, Taguchi K, Takesue Y, Matsumoto K. Samura M, et al. Pharmaceutics. 2022 Mar 27;14(4):714. doi: 10.3390/pharmaceutics14040714. Pharmaceutics. 2022. PMID: 35456548 Free PMC article. Review.
96 results